SG11201506153TA - Helicase-primase inhibitors for use in a method of treating alzheimer's disease - Google Patents
Helicase-primase inhibitors for use in a method of treating alzheimer's diseaseInfo
- Publication number
- SG11201506153TA SG11201506153TA SG11201506153TA SG11201506153TA SG11201506153TA SG 11201506153T A SG11201506153T A SG 11201506153TA SG 11201506153T A SG11201506153T A SG 11201506153TA SG 11201506153T A SG11201506153T A SG 11201506153TA SG 11201506153T A SG11201506153T A SG 11201506153TA
- Authority
- SG
- Singapore
- Prior art keywords
- helicase
- disease
- treating alzheimer
- primase inhibitors
- primase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13154982 | 2013-02-12 | ||
| PCT/EP2014/052743 WO2014124978A2 (en) | 2013-02-12 | 2014-02-12 | Helicase-primase inhibitors for use in a method of treating alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201506153TA true SG11201506153TA (en) | 2015-09-29 |
Family
ID=47709982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506153TA SG11201506153TA (en) | 2013-02-12 | 2014-02-12 | Helicase-primase inhibitors for use in a method of treating alzheimer's disease |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150374676A1 (ja) |
| EP (1) | EP2956134A2 (ja) |
| JP (1) | JP2016507546A (ja) |
| KR (1) | KR20150119089A (ja) |
| CN (1) | CN105101963A (ja) |
| AU (1) | AU2014217962A1 (ja) |
| BR (1) | BR112015019220A2 (ja) |
| CA (1) | CA2898798A1 (ja) |
| CL (1) | CL2015002241A1 (ja) |
| EA (1) | EA201500836A1 (ja) |
| IL (1) | IL240459A0 (ja) |
| MX (1) | MX2015010339A (ja) |
| PH (1) | PH12015501762A1 (ja) |
| SG (1) | SG11201506153TA (ja) |
| WO (1) | WO2014124978A2 (ja) |
| ZA (1) | ZA201505243B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2573085A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
| HUE054845T2 (hu) * | 2016-11-28 | 2021-10-28 | Aicuris Gmbh & Co Kg | Az N-[5-(amino-szulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamid szabad bázis maleát sója, gyógyászati készítmények, elõállítási eljárások és Herpes vírusok kezelésére történõ alkalmazások |
| US11439608B2 (en) | 2017-09-25 | 2022-09-13 | Qun Lu | Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease |
| TW202038947A (zh) * | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
| KR102456699B1 (ko) | 2020-11-19 | 2022-10-19 | 주식회사 오에이티씨 | 디다노신을 포함하는 신경염증성 질환 예방 또는 치료용 조성물 |
| WO2024047508A1 (en) * | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
| US8299059B2 (en) * | 2009-10-30 | 2012-10-30 | Eli Lilly And Company | Crystalline compound and a process for its preparation |
| EP2573085A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
-
2014
- 2014-02-12 CN CN201480008550.6A patent/CN105101963A/zh active Pending
- 2014-02-12 SG SG11201506153TA patent/SG11201506153TA/en unknown
- 2014-02-12 MX MX2015010339A patent/MX2015010339A/es unknown
- 2014-02-12 CA CA2898798A patent/CA2898798A1/en not_active Abandoned
- 2014-02-12 EP EP14703891.3A patent/EP2956134A2/en not_active Withdrawn
- 2014-02-12 KR KR1020157024625A patent/KR20150119089A/ko not_active Application Discontinuation
- 2014-02-12 WO PCT/EP2014/052743 patent/WO2014124978A2/en active Application Filing
- 2014-02-12 AU AU2014217962A patent/AU2014217962A1/en not_active Abandoned
- 2014-02-12 BR BR112015019220A patent/BR112015019220A2/pt not_active IP Right Cessation
- 2014-02-12 US US14/767,163 patent/US20150374676A1/en not_active Abandoned
- 2014-02-12 EA EA201500836A patent/EA201500836A1/ru unknown
- 2014-02-12 JP JP2015556537A patent/JP2016507546A/ja not_active Withdrawn
-
2015
- 2015-07-21 ZA ZA2015/05243A patent/ZA201505243B/en unknown
- 2015-08-09 IL IL240459A patent/IL240459A0/en unknown
- 2015-08-11 PH PH12015501762A patent/PH12015501762A1/en unknown
- 2015-08-11 CL CL2015002241A patent/CL2015002241A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014124978A4 (en) | 2014-12-24 |
| MX2015010339A (es) | 2015-11-16 |
| KR20150119089A (ko) | 2015-10-23 |
| PH12015501762A1 (en) | 2015-11-09 |
| EP2956134A2 (en) | 2015-12-23 |
| IL240459A0 (en) | 2015-09-24 |
| CA2898798A1 (en) | 2014-08-21 |
| AU2014217962A1 (en) | 2015-09-17 |
| WO2014124978A3 (en) | 2014-10-30 |
| JP2016507546A (ja) | 2016-03-10 |
| US20150374676A1 (en) | 2015-12-31 |
| WO2014124978A2 (en) | 2014-08-21 |
| ZA201505243B (en) | 2017-11-29 |
| EA201500836A1 (ru) | 2016-02-29 |
| CN105101963A (zh) | 2015-11-25 |
| CL2015002241A1 (es) | 2016-02-19 |
| BR112015019220A2 (pt) | 2017-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266648B (en) | A method for treating Parkinson's disease | |
| HK1225305A1 (zh) | 治療腦疾病的方法和組合物 | |
| EP3019523A4 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE | |
| HK1222530A1 (zh) | 用於皮膚處理的微閉合及相關方法 | |
| IL278124B (en) | Axl depressant pyridone derivative for use in the treatment of the disease | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| HK1212972A1 (zh) | 作爲 -蛋白抑制劑用於治療過度增殖性疾病的吡咯並-和吡唑並-三唑並二氮雜卓 | |
| EP2992908A4 (en) | METHOD FOR THE SURFACE TREATMENT OF AN IMPLANT | |
| SG11201509729YA (en) | Use of high dose pridopidine for treating huntington's disease | |
| ZA201505243B (en) | Helicase-primase inhibitors for use in a method of treating alzheimer's disease | |
| PT2948448T (pt) | Análogos de tiadiazol e o seu uso para tratamento de doenças associadas a uma deficiência de neurónios motores smn | |
| EP2978446A4 (en) | METHODS AND AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| EP2844271A4 (en) | PROCESSING METHOD AND AGENTS USEFUL THEREFOR | |
| HK1215373A1 (zh) | 用於治療代謝疾病的方法和裝置 | |
| HK1217448A1 (zh) | 乙酰輔酶 羧化酶抑制劑用於治療尋常痤瘡的用途 | |
| EP2941252A4 (en) | USE OF FATTY ACID NIACIN CONJUGATES FOR THE TREATMENT OF DISEASES | |
| IL240812B (en) | Unit and method for corona treatment | |
| BR112014029487A2 (pt) | método para o tratamento cosmético | |
| PL3041831T3 (pl) | Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby | |
| EP2968452A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF NETWORK DISEASES | |
| LT2978846T (lt) | Modifikuotas tgf-beta oligonukleotidas, skirtas panaudoti akių ligų prevencijos ir (arba) gydymo būdui | |
| EP2854784A4 (en) | METHOD OF TREATING INFLAMMATORY SKIN DISEASES | |
| ZA201407215B (en) | Method for emulsion treatment | |
| IL241482A0 (en) | A method for treating Parkinson's disease | |
| ZA201302565B (en) | Methods for treating hyperuricemia and related diseases |